Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Eric Tarride

Showing results (61-70 of 215) with videos related to

Pageof 22
Sort By:
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|June 9, 2017
What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic ReviewJathishinie Jegathisawaran, Anne Holbrook, James M Bowen, et al.
Pharmacoeconomics - Open|August 5, 2024
Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) AnalysesFatemeh Mirzayeh Fashami, Jean-Eric Tarride, Behnam Sadeghirad, et al.
International Journal of Technology Assessment in Health Care|September 21, 2006
Measuring quality of life: the development and initial validation of the patient-reported erectile function assessment instrumentGeorge W Torrance, Margaret-Anne Keresteci, Richard Casey, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|June 18, 2009
The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06Daria J O'Reilly, Ron A Goeree, Jean-Eric Tarride, et al.
Pharmacoeconomics - Open|September 17, 2024
Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) AnalysesFatemeh Mirzayeh Fashami, Jean-Eric Tarride, Behnam Sadeghirad, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 12, 2012
Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescentsJean-Eric Tarride, Natasha Burke, Camilla Von Keyserlingk, et al.
Pilot and Feasibility Studies|September 7, 2023
Motivational interviewing to promote healthy behaviors for obesity prevention in young adults (MOTIVATE): a pilot randomized controlled trial protocolLaura N Anderson, Elizabeth Alvarez, Taylor Incze, et al.
International Journal of Technology Assessment in Health Care|October 23, 2009
Handling uncertainty in economic evaluations of patient level data: a review of the use of Bayesian methods to inform health technology assessmentsC Elizabeth McCarron, Eleanor M Pullenayegum, Deborah A Marshall, et al.
International Journal of Technology Assessment in Health Care|May 8, 2012
Mathematical modeling: the case of emergency department waiting timesMorgan E Lim, Tim Nye, James M Bowen, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and applicationRon Goeree, Jing He, Daria O'Reilly, et al.
Pageof 22

Showing results (61-70 of 215) with videos related to

Sort By:
Pageof 22
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|June 9, 2017
What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic ReviewJathishinie Jegathisawaran, Anne Holbrook, James M Bowen, et al.
Pharmacoeconomics - Open|August 5, 2024
Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) AnalysesFatemeh Mirzayeh Fashami, Jean-Eric Tarride, Behnam Sadeghirad, et al.
International Journal of Technology Assessment in Health Care|September 21, 2006
Measuring quality of life: the development and initial validation of the patient-reported erectile function assessment instrumentGeorge W Torrance, Margaret-Anne Keresteci, Richard Casey, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|June 18, 2009
The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06Daria J O'Reilly, Ron A Goeree, Jean-Eric Tarride, et al.
Pharmacoeconomics - Open|September 17, 2024
Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) AnalysesFatemeh Mirzayeh Fashami, Jean-Eric Tarride, Behnam Sadeghirad, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 12, 2012
Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescentsJean-Eric Tarride, Natasha Burke, Camilla Von Keyserlingk, et al.
Pilot and Feasibility Studies|September 7, 2023
Motivational interviewing to promote healthy behaviors for obesity prevention in young adults (MOTIVATE): a pilot randomized controlled trial protocolLaura N Anderson, Elizabeth Alvarez, Taylor Incze, et al.
International Journal of Technology Assessment in Health Care|October 23, 2009
Handling uncertainty in economic evaluations of patient level data: a review of the use of Bayesian methods to inform health technology assessmentsC Elizabeth McCarron, Eleanor M Pullenayegum, Deborah A Marshall, et al.
International Journal of Technology Assessment in Health Care|May 8, 2012
Mathematical modeling: the case of emergency department waiting timesMorgan E Lim, Tim Nye, James M Bowen, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and applicationRon Goeree, Jing He, Daria O'Reilly, et al.
Pageof 22